Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% from ...

Alembic Pharmaceuticals’ joint venture, Aleor Dermaceuticals, has received approval from the Food and Drug Administration for its generic Metrogel Gel (metronidazole gel, 1%). The topical gel is ...

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel. The ...

CHICAGO – Application of a new formulation of azelaic acid gel to the face reduces the redness and lesions associated with rosacea better than a commonly used treatment (metronidazole gel), according ...

Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea Capsules, 40 mg, in Combination with MetroGel® (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of ...

March 26, 2003 (San Francisco) — Results of a head-to-head open-label trial comparing azelaic acid 15% to metronidazole standard therapy for the treatment of moderate papulopustular facial rosacea ...

CINCINNATI--(BUSINESS WIRE)--Prasco Laboratories, a Cincinnati-based pharmaceutical company, announced today it has entered into a distribution and supply agreement with Graceway Pharmaceuticals, LLC.

HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its ...

Metronidazole 0.75%; vaginal gel; contains parabens. Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B).

Background: Women with cervicitis frequently have bacterial vaginosis (BV). Prior studies have suggested that BV is involved in the pathogenesis of cervicitis. Goals: To delineate the association of ...

(Reuters Health) - Researchers say they have cut the recurrence rate of bacterial vaginosis by one third using an experimental treatment that injects a bacterium known as Lactin-V into the vagina to ...